Vascular endothelial growth factor response to exogenous chorionic gonadotropic hormone in the luteal phase of women with a history of severe ovarian hyperstimulation syndrome

Griesinger, Georg; Dafopoulos, Konstantinos; Schultze-Mosgau, Askan; Jelkmann, Wolfgang; von Otte, Soeren; Diesing, Dagmar; Diedrich, Klaus
April 2006
Archives of Gynecology & Obstetrics;Apr2006, Vol. 274 Issue 1, p29
Academic Journal
Ovarian hyperstimulation syndrome (OHSS) is a severe complication of ovarian stimulation. No reliable test exists to predict the syndrome. The objective of the present prospective observational study was to examine vascular endothelial growth factor (VEGF) secretion after human chorionic gonadotropin (hCG) administration in the luteal phase of a spontaneous cycle of women with a history of severe OHSS. Five women with a history of severe OHSS were administered 250 μg recombinant hCG intravenously on day 21 of a spontaneous menstrual cycle. Plasma samples were collected at regular intervals from 15 min before hCG to 6 h thereafter and the free VEGF plasma concentrations were determined. Plasma levels of free VEGF remained at the lower detection limit of the assay throughout the observational period. Women with previous severe OHSS do not show a significant short-time response of VEGF secretion upon hCG administration. No evidence was found to support the notion that women inclined to develop a severe form of the syndrome after ovarian stimulation could possibly be identified by the VEGF short-time secretory response to exogenous hCG in the luteal phase of a spontaneous cycle.


Related Articles

  • Plasma levels of soluble vascular endothelial growth factor receptor-1 may determine the onset of early and late ovarian hyperstimulation syndrome. Elena Pau; Isabel Alonso-Muriel; Raul Gómez; Edurne Novella; Amparo Ruiz; Juan A. García-Velasco; Carlos Simón; Antonio Pellicer // Human Reproduction;Jun2006, Vol. 21 Issue 6, p1453 

    BACKGROUND: Ovarian hyperstimulation syndrome (OHSS) is a life-threatening condition associated with ovarian stimulation. Its pathophysiology is unknown and its treatment continues to be empirical. Early (E)- and late (L)-OHSS occur in women at risk, though not in all cases. Vascular endothelial...

  • Genetics of ovarian hyperstimulation syndrome. Rizk, Botros // Reproductive BioMedicine Online (Reproductive Healthcare Limited;Jul2009, Vol. 19 Issue 1, p14 

    Sporadic and familial cases of spontaneous OHSS have generated an interest in genetic mechanisms for OHSS independent of exogenous gonadotrophins. The genetic studies have addressed the genes and receptors for FSH and luteinizing/human chorionic gonadotrophin hormones. Mutations in the FSH...

  • Molecular mechanisms of ovarian hyperstimulation syndrome: paracrine reduction of endothelial claudin 5 by hCG in vitro is associated with increased endothelial permeability. M. Rodewald; D. Herr; W.C. Duncan; H.M. Fraser; G. Hack; R. Konrad; F. Gagsteiger; R. Kreienberg; C. Wulff // Human Reproduction;May2009, Vol. 24 Issue 5, p1191 

    BACKGROUND Ovarian hyperstimulation syndrome (OHSS) is a potentially life-threatening complication of ovarian stimulation associated with severe vascular hyperpermeability. Primary co-cultures of human luteinized granulosa cells (LGCs) and human umbilical vein endothelial cells (HUVECs) were...

  • VEGF Response to hCG Not Higher with Previous Severe OHSS.  // Fertility Weekly;5/22/2006, p5 

    The article reports on the study conducted by researchers in Germany which found that women with ovarian hyperstimulation syndrome (OHSS) do not have a short-time response of vascular endothelial growth factor secretion with administration of hCG. Five women with a history of severe OHSS was...

  • Chorionic gonadotrophin, genes and embryonic signals regulating the implantation window. Edwards, R. G. // Reproductive BioMedicine Online (Reproductive Healthcare Limited;Apr2007, Vol. 14 Issue 4, p538 

    The article reports on two studies on the factors chorionic gonadotrophin (CG), genes and embryonic signals that are operating during the implantation window. The first study focused on CG and its role in sustaining the endometrium of the baboon during the preimplantation period. The other study...

  • Ovarian hyperstimulation syndrome. Kumar, Pratap; Sait, Sameer Farouk; Sharma, Alok; Kumar, Mukesh // Journal of Human Reproductive Sciences;May-Aug2011, Vol. 4 Issue 2, p70 

    Ovarian hyperstimulation syndrome (OHSS) is an iatrogenic complication of assisted reproduction technology. The syndrome is characterized by cystic enlargement of the ovaries and a fluid shift from the intravascular to the third space due to increased capillary permeability and ovarian...

  • Ability to Secrete sVEGFR-1 Determines Onset. Pellicer, Antonio // Fertility Weekly;7/24/2006-7/31/2006, p4 

    The article presents a study which analyzes the dynamics of the vascular endothelial growth factor (VEGF) in early and late ovarian hyperstimulation syndrome (OHSS). VEGF is known to play a crucial role in OHSS. VEGF-1 is produced as soluble receptor that serves as a modulator of VEGF...

  • Trial of support treatment with human chorionic gonadotrophin in the luteal phase after treatment with buserelin and human menopausal gonadotrophin in women taking part in an in vitro fertilisation programme. Smith, Elaine M.; Anthony, Fred W.; Gadd, Stephanie C.; Masson, Gordon M. // BMJ: British Medical Journal (International Edition);6/3/89, Vol. 298 Issue 6686, p1483 

    Evaluates the effect of treatment with human chorionic gonadotrophin in the luteal phase after treatment with buserelin and human menopausal gonadotrophin. Beneficial effects of buserelin and human menopausal in vitro fertilization; Suppression of the pituitary with buserelin; Hyperstimulation...

  • Pinopode formation upon progesterone and hCG treatments as luteal phase support. Kabir-salmani, M.; Favaedi, M.; Taheripanah, R. // Iranian Journal of Reproductive Medicine;Jun2014 Supplement, Vol. 12, p36 

    Introduction: Induction of ovulation is one of the primary steps in assisted reproduction while considered as one of the main reasons for endometrial inadequacy. Hormonal treatment as a luteal phase support appeared to improve pregnancy rates, however, little is known about endometrium status...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics